Showing results (11-20 of 276) with videos related to
Sort By:
Pageof 28
Thrombosis Research|September 25, 2001
Thrombolytic therapy. State of the artP Sinnaeve, F Van de WerfCirculation|June 1, 1993
Coronary thrombolysis with recombinant staphylokinase in patients with evolving myocardial infarctionD Collen, F Van de WerfThe American Journal of Cardiology|September 1, 1987
Coronary arterial thrombolysis with low-dose synergistic combinations of recombinant tissue-type plasminogen activator (rt-PA) and recombinant single-chain urokinase-type plasminogen activator (rscu-PA) for acute myocardial infarctionD Collen, F Van de WerfBMJ (Clinical Research Ed.)|November 26, 1988
Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarctionF Van de Werf, A E ArnoldThrombosis and Haemostasis|March 1, 2000
TNK-tPA for acute myocardial infarction: the clinical experienceS V Pislaru, F Van de WerfAmerican Heart Journal|August 1, 1997
Randomized coronary patency trial of double-bolus recombinant staphylokinase versus front-loaded alteplase in acute myocardial infarctionS Vanderschueren, J Dens, P Kerdsinchai, et al.Annals of Internal Medicine|March 1, 1986
Coronary thrombolysis with human single-chain, urokinase-type plasminogen activator (pro-urokinase) in patients with acute myocardial infarctionF Van de Werf, M Nobuhara, D CollenPageof 28